Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | H.A. Yu, G.R. Oxnard, A.I. Spira, L. Horn, J. Weiss, Y.Feng, H.J. West, G. Giaccone, T. L. Evans, R.J. Kelly, T.Fleege, S. Poondru, F. Jie, K. Aoyama, M.A. Foley, D. Whitcomb, A. T. Keating, A. P. Krivoshik | ||||||||||||
Title | ASP8273, a mutant-selective irreversible EGFR inhibitor in patients (pts) with NSCLC harboring EGFR activating mutations: Preliminary results of first-in-human phase I study in Japan. | ||||||||||||
|
|||||||||||||
URL | http://meetinglibrary.asco.org/content/147772-156 | ||||||||||||
Abstract Text | J Clin Oncol 33, 2015 (suppl; abstr 8083) |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|